Paterson, David L. MBBS, FRACP, FRCPA, PhD; Lipman, Jeffrey MBBCh, DA, FFA, FJFICM, MD
Author Information
Royal Brisbane and Women’s Hospital, University of Queensland, Brisbane, Australia
Dr. Lipman has received grant funding from AstraZeneca. Dr. Paterson has received grant funding from Merck, Elan, Pfizer, and AstraZeneca and is a consultant to Acureon, Johnson and Johnson, and Merck.
doi: 10.1097/01.CCM.0000269352.39174.A4
